A detailed history of Key F Inancial Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Key F Inancial Inc holds 6,941 shares of BMY stock, worth $369,400. This represents 0.07% of its overall portfolio holdings.

Number of Shares
6,941
Previous 6,941 -0.0%
Holding current value
$369,400
Previous $376,000 23.4%
% of portfolio
0.07%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$48.48 - $57.85 $2,957 - $3,528
61 Added 0.89%
6,941 $356,000
Q3 2023

Nov 01, 2023

SELL
$57.89 - $64.73 $10,535 - $11,780
-182 Reduced 2.58%
6,880 $399,000
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $11,595 - $12,874
182 Added 2.65%
7,062 $451,000
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $57,956 - $65,735
-882 Reduced 11.36%
6,880 $476,000
Q3 2022

Oct 28, 2022

BUY
$0.13 - $76.84 $273 - $161,364
2,100 Added 37.09%
7,762 $552,000
Q2 2022

Jul 26, 2022

BUY
$72.62 - $79.98 $9,077 - $9,997
125 Added 2.26%
5,662 $435,000
Q1 2022

Apr 27, 2022

BUY
$61.48 - $73.72 $88,900 - $106,599
1,446 Added 35.35%
5,537 $404,000
Q4 2021

Jan 19, 2022

BUY
$53.63 - $62.52 $18,341 - $21,381
342 Added 9.12%
4,091 $255,000
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $12,307 - $14,416
208 Added 5.87%
3,749 $222,000
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $91,750 - $99,916
-1,482 Reduced 29.5%
3,541 $240,000
Q1 2021

Apr 30, 2021

BUY
$59.34 - $66.74 $98,741 - $111,055
1,664 Added 49.54%
5,023 $317,000
Q4 2020

Jan 29, 2021

SELL
$57.74 - $65.43 $94,231 - $106,781
-1,632 Reduced 32.7%
3,359 $208,000
Q3 2020

Nov 02, 2020

BUY
$57.43 - $63.64 $286,633 - $317,627
4,991 New
4,991 $301,000
Q2 2020

Aug 07, 2020

SELL
$54.82 - $64.09 $271,633 - $317,565
-4,955 Closed
0 $0
Q1 2020

May 05, 2020

SELL
$46.4 - $67.43 $83,520 - $121,374
-1,800 Reduced 26.65%
4,955 $272,000
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $332,413 - $433,603
6,755 New
6,755 $434,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Key F Inancial Inc Portfolio

Follow Key F Inancial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Key F Inancial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Key F Inancial Inc with notifications on news.